Partner Content

R&D

Partner Content

Aktiia Receives Regulatory Approval for the World’s First Op...

Aktiia has received regulatory approval for the world’s first optical blood pressure system that doesn’t require calibration with a traditional cuff!

R&D

Partner Content

6th Macrophage-Directed Therapies Summit

Unravel Complex Macrophage Biology, Accelerate Novel Target Discovery, & Drive Clinical Proof of Concept to Deliver the Blockbuster Potential of Macro

R&D

Partner Content

3rd mRNA Process Development & Manufacturing Summit

Your Roadmap for mRNA Process Development & Manufacturing with Optimized Purification, Process Analytics & Enhanced Formulation to Improve Cost-Effectiveness & Scalability into

R&D

Partner Content

2nd mRNA Quality Control & Compliance Summit

The 2nd mRNA Quality Control & Compliance Summit 2024 returns this June 25-27 (Boston, MA), as the sole industry-centred forum dedicated to showcasing technical data and though

R&D

Partner Content

The 9th CAR-TCR Summit Returns to Boston!

The commercial success of cell therapies is continuing to grow!

R&D

Partner Content

Final FDA rule on LDTs creates a paradigm shift for laborato...

WASHINGTON, D.C., April 30, 2024 –The Food and Drug Administration’s (FDA) final rule has reclassified laboratory developed tests (LDTs) as medical devices, according to Avalere.

Aktiia Receives Regulatory Approval for the World’s First Op...

6th Macrophage-Directed Therapies Summit

3rd mRNA Process Development & Manufacturing Summit

2nd mRNA Quality Control & Compliance Summit

The 9th CAR-TCR Summit Returns to Boston!

Final FDA rule on LDTs creates a paradigm shift for laborato...

CDC panel votes to scrap hepatitis B birth dose advice

How to meet your physicians where they are online

Partner Content

Editor's Picks